Disruption of podocyte cytoskeletal biomechanics by dasatinib leads to nephrotoxicity-Reference-Cited by-同舟云学术

Disruption of podocyte cytoskeletal biomechanics by dasatinib leads to nephrotoxicity

Published:2019-05-03 Issue:1 Volume:10 Page:
ISSN:2041-1723
Container-title:Nature Communications
language:en
Short-container-title:Nat Commun

Author:

Calizo Rhodora C.,Bhattacharya Smiti,van Hasselt J. G. Coen^ORCID,Wei Chengguo,Wong Jenny S.,Wiener Robert J.,Ge Xuhua,Wong Nicholas J.,Lee Jia-Jye,Cuttitta Christina M.,Jayaraman Gomathi,Au Vivienne H.,Janssen William,Liu Tong,Li Hong,Salem Fadi,Jaimes Edgar A.,Murphy Barbara^ORCID,Campbell Kirk N.,Azeloglu Evren U.^ORCID

Publisher

Springer Science and Business Media LLC

Subject

General Physics and Astronomy,General Biochemistry, Genetics and Molecular Biology,General Chemistry

Link

http://www.nature.com/articles/s41467-019-09936-x.pdf

Reference61 articles.

1. Wheler, J. J. et al. Risk of serious toxicity in 1181 patients treated in phase I clinical trials of predominantly targeted anticancer drugs: the M. D. Anderson Cancer Center experience. Ann. Oncol. 23, 1963–1967 (2012).

2. Wong, G. et al. Association of CKD and cancer risk in older people. J. Am. Soc. Nephrol. 20, 1341–1350 (2009).

3. Launay-Vacher, V. et al. Renal effects of molecular targeted therapies in oncology: a review by the Cancer and the Kidney International Network (C-KIN). Ann. Oncol. 26, 1677–1684 (2015).

4. Abbas, A., Mirza, M. M., Ganti, A. K. & Tendulkar, K. Renal toxicities of targeted therapies. Target Oncol. 10, 487–499 (2015).

5. Downing, N. S. et al. Postmarket safety events among novel therapeutics approved by the US Food and Drug Administration between 2001 and 2010. JAMA 317, 1854–1863 (2017).

Cited by 56 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A high-throughput microfabricated platform for rapid quantification of metastatic potential;Science Advances;2024-08-16

2. Procyanidin C1 inhibits bleomycin‐induced pulmonary fibrosis in mice by selective clearance of senescent myofibroblasts;The FASEB Journal;2024-06-21

3. Ocular and systemic vascular endothelial growth factor ligand inhibitor use and nephrotoxicity: an update;International Urology and Nephrology;2024-03-18

4. Role of biophysics and mechanobiology in podocyte physiology;Nature Reviews Nephrology;2024-03-05

5. Glomerular Elasticity and Gene Expression Patterns Define Two Phases of Alport Nephropathy;2024-02-29